Compare RPID & GCV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RPID | GCV |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 84.8M | 92.5M |
| IPO Year | 2021 | 1994 |
| Metric | RPID | GCV |
|---|---|---|
| Price | $1.17 | $4.51 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 220.6K | 30.4K |
| Earning Date | 05-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 2.78 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $33,587,000.00 | N/A |
| Revenue This Year | $19.12 | N/A |
| Revenue Next Year | $18.42 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 19.74 | N/A |
| 52 Week Low | $1.16 | $3.98 |
| 52 Week High | $4.94 | $4.80 |
| Indicator | RPID | GCV |
|---|---|---|
| Relative Strength Index (RSI) | 20.64 | 43.79 |
| Support Level | N/A | $4.52 |
| Resistance Level | $2.18 | $4.76 |
| Average True Range (ATR) | 0.10 | 0.06 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 2.66 | 30.33 |
Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.
GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC is a diversified closed-end management investment company. Its investment objective is to seek a high level of total return through a combination of current income and capital appreciation by investing in convertible securities. The company invests in various portfolios such as Health Care, Financial Services, Real Estate Investment Trust, Energy and Utilities, Telecommunications, Food and Beverage, Aerospace and Automotive, and others. All the operation of the group is operated through the regions of the United States.